封面
市場調查報告書
商品編碼
1588460

壓縮機霧化器市場規模、佔有率和趨勢分析報告:按適應症、最終用途、地區、細分市場預測,2025-2030 年

Pneumatic Nebulizers Market Size, Share & Trends Analysis Report By Indication (Breath-actuated, Vented), By End-use (Hospitals & Clinics, Home Healthcare), By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

壓縮機霧化器市場成長與趨勢:

根據Grand View Research, Inc.最新報告,預計2030年全球壓縮機霧化器市場規模將達11.6674億美元,2025年至2030年複合年成長率為6.5%。

近年來,隨著家庭醫療保健設備的普及,壓縮機式霧化器的市場採用量出現了一定的成長。產品小型化和技術進步也推動了家庭醫療保健設備的採用。

據明尼蘇達州衛生署稱,與其他產生氣溶膠的手術相比,使用霧化器給藥的感染風險較低。另一方面,根據 ISAM 的說法,霧化器產生的氣溶膠不攜帶患者來源的病毒顆粒,因為它們源自於霧化室中的液體,而霧化室中的液體不是患者來源。只有當醫護人員或病患污染了霧化器時,霧化器產生的氣溶膠才含有病原體。儘管各機構提出了各種建議,但尚不清楚在大流行期間是否適合使用霧化器。

然而,尚無已知的霧化器被動感染案例。即使有感染風險,也可以透過採取適當的 COVID-19 預防措施來避免。因此,疫情對整個市場僅產生了一定的影響。革命性的技術進步正在迅速改變市場。這種擴張正在創造利潤豐厚的可能性。例如,2019 年 3 月,Breath Technologies 宣布啟動 L-CSA-i 的 3 期波士頓臨床試驗,透過 PARI Pharma 的研究藥物特異性eFlow 霧化器治療阻塞性細支氣管炎症候群。

壓縮機霧化器市場報告亮點

  • 據顯示,2024 年呼吸驅動細分市場的收益佔有率64.06%。呼吸驅動霧化器具有更高的藥物傳輸能力和更低的劑量浪費。因此,提供先進吸入療法的細分市場預計將在預測期內主導市場。
  • 2024 年,醫院和診所細分市場佔據最大市場佔有率。擴大採用壓縮機動力霧化器來治療氣喘和慢性阻塞性肺病(COPD) 等急性呼吸道疾病,這推動了該行業的成長。
  • 北美壓縮機霧化器市場在 2024 年佔據主導地位,收益佔有率為 35.28%,由於呼吸系統疾病盛行率的增加和霧化器技術的進步,預計在預測期內將出現成長。
  • 預計亞太地區在預測期內將以最快的複合年成長率成長。亞洲慢性阻塞性肺病的負擔比西方已開發國家更大。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
    • 產業分析-波特五力分析
    • PESTLE分析

第4章 指標業務分析

  • 2024年及2030年指示市場佔有率
  • 指示細分儀表板
  • 2018-2030 年市場規模、預測與趨勢分析(依指標)
  • 呼吸激活
  • 發洩

第5章 最終用途業務分析

  • 2024 年及 2030 年最終用途市場佔有率
  • 最終用途細分儀表板
  • 2018-2030 年按最終用途分類的市場規模、預測與趨勢分析
  • 醫院/診所
  • 家庭保健

第 6 章 區域估計/趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析:
  • 北美洲
    • 2018-2030年北美壓縮機式霧化器市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030年歐洲壓縮機式霧化器市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 2018-2030 年亞太地區壓縮機霧化器市場估計與預測
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 2018-2030年拉丁美洲壓縮機式霧化器市場估計與預測
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 2018-2030年中東和非洲氣動霧化器市場估計與預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 參與企業概況
  • 公司市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介
    • Koninklijke Philips NV
    • OMRON Corporation
    • Cook Medical PARI GmbH
    • General Electric
    • Allied Healthcare Products, Inc.
    • BD(Becton, Dickinson &Company)
    • GF Health Products, Inc.
    • Medline Industries, LP
    • Briggs Healthcare
    • Vectura Group Ltd
Product Code: GVR-1-68038-194-8

Pneumatic Nebulizers Market Growth & Trends:

The global pneumatic nebulizers market size is expected to reach USD 1,166.74 million by 2030, registering a CAGR of 6.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market has shown constant growth in the adoption of pneumatic nebulizers as home healthcare devices have been gaining popularity in recent years. Miniaturization of products and technological advancements are also boosting the adoption of home healthcare devices.

As per the Minnesota Department of Health, administration of medication through nebulizer represents a lower infection risk as compared to other aerosol-producing procedures. On the other hand, according to ISAM, aerosols from the nebulizer do not carry viral particles derived from the patient as they are generated from the fluid in the nebulized chamber, which is a non-patient source. Aerosols generated by nebulizers comprise pathogens only when the healthcare workers or patients contaminate the nebulizers. Various recommendations from institutes do not clarify whether it is appropriate to use nebulizers during the pandemic.

However, there are no known cases of passive infection due to nebulizers. Also, the risk of infection, if any, can be avoided if proper COVID-19 precautions are taken. Therefore, the pandemic affected the overall market only to a certain extent. Revolutionary technological progress is rapidly transforming the market. These expansions are producing lucrative potentials. For instance, in March 2019, Breath Technologies announced the initiation of Phase 3 BOSTON clinical study of L-CsA-i for the treatment of bronchiolitis obliterans syndrome via a drug-specific eFlow nebulizer of PARI Pharma that is under investigation.

Pneumatic Nebulizers Market Report Highlights:

  • Based on indication, the breath-actuated segment held the largest revenue share 64.06% in 2024. Breath-actuated nebulizers elucidate higher drug delivery capacity and lesser dosage wastage features. Thus, the segment delivering advanced inhalation therapy is expected to dominate the market over the forecast period.
  • Hospitals & clinics segment held the largest market share in 2024. The increasing adoption of pneumatic nebulizers for the management of acute respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD) is fueling the segment growth.
  • North America pneumatic nebulizers market dominated with a revenue share of 35.28% in 2024 and is poised to grow over the forecast period owing to the increasing prevalence of respiratory diseases and advancements in nebulizer technology.
  • Asia Pacific is expected to grow at the fastest CAGR over the forecast period. The burden of COPD in Asia is greater than that in developed Western countries.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Indication
    • 1.2.2. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
    • 3.2.5. Industry Analysis - Porter's Five Forces Analysis
      • 3.2.5.1. Supplier power
      • 3.2.5.2. Buyer power
      • 3.2.5.3. Substitution threat
      • 3.2.5.4. Threat of new entrant
      • 3.2.5.5. Competitive rivalry
    • 3.2.6. PESTLE Analysis

Chapter 4. Indication Business Analysis

  • 4.1. Indication Market Share, 2024 & 2030
  • 4.2. Indication Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 4.4. Breath-actuated
    • 4.4.1. Breath-actuated market, 2018 - 2030 (USD Million)
  • 4.5. Vented
    • 4.5.1. Vented market, 2018 - 2030 (USD Million)

Chapter 5. End Use Business Analysis

  • 5.1. End Use Market Share, 2024 & 2030
  • 5.2. End Use Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals & Clinics
    • 5.4.1. Hospitals & clinics market, 2018 - 2030 (USD Million)
  • 5.5. Home Healthcare
    • 5.5.1. Home healthcare market, 2018 - 2030 (USD Million)

Chapter 6. Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key country dynamic
      • 6.4.2.2. Regulatory framework/reimbursement scenario
      • 6.4.2.3. U.S. pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key country dynamic
      • 6.4.3.2. Regulatory framework/reimbursement scenario
      • 6.4.3.3. Canada pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key country dynamic
      • 6.4.4.2. Regulatory framework/reimbursement scenario
      • 6.4.4.3. Mexico pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key country dynamic
      • 6.5.2.2. Regulatory framework/reimbursement scenario
      • 6.5.2.3. UK pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key country dynamic
      • 6.5.3.2. Regulatory framework/reimbursement scenario
      • 6.5.3.3. Germany pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key country dynamic
      • 6.5.4.2. Regulatory framework/reimbursement scenario
      • 6.5.4.3. France pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key country dynamic
      • 6.5.5.2. Regulatory framework/reimbursement scenario
      • 6.5.5.3. Italy pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key country dynamic
      • 6.5.6.2. Regulatory framework/reimbursement scenario
      • 6.5.6.3. Spain pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Norway
      • 6.5.7.1. Key country dynamic
      • 6.5.7.2. Regulatory framework/reimbursement scenario
      • 6.5.7.3. Norway pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key country dynamic
      • 6.5.8.2. Regulatory framework/reimbursement scenario
      • 6.5.8.3. Denmark pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key country dynamic
      • 6.5.9.2. Regulatory framework/reimbursement scenario
      • 6.5.9.3. Sweden pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key country dynamic
      • 6.6.2.2. Regulatory framework/reimbursement scenario
      • 6.6.2.3. Japan pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key country dynamic
      • 6.6.3.2. Regulatory framework/reimbursement scenario
      • 6.6.3.3. China pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key country dynamic
      • 6.6.4.2. Regulatory framework/reimbursement scenario
      • 6.6.4.3. India pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key country dynamic
      • 6.6.5.2. Regulatory framework/reimbursement scenario
      • 6.6.5.3. South Korea pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key country dynamic
      • 6.6.6.2. Regulatory framework/reimbursement scenario
      • 6.6.6.3. Australia pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key country dynamic
      • 6.6.7.2. Regulatory framework/reimbursement scenario
      • 6.6.7.3. Thailand pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key country dynamic
      • 6.7.2.2. Regulatory framework/reimbursement scenario
      • 6.7.2.3. Brazil pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key country dynamic
      • 6.7.3.2. Regulatory framework/reimbursement scenario
      • 6.7.3.3. Argentina pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key country dynamic
      • 6.8.2.2. Regulatory framework/reimbursement scenario
      • 6.8.2.3. South Africa pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key country dynamic
      • 6.8.3.2. Regulatory framework/reimbursement scenario
      • 6.8.3.3. Saudi Arabia pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key country dynamic
      • 6.8.4.2. Regulatory framework/reimbursement scenario
      • 6.8.4.3. UAE pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key country dynamic
      • 6.8.5.2. Regulatory framework/reimbursement scenario
      • 6.8.5.3. Kuwait pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Koninklijke Philips N.V.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial performance
      • 7.5.1.3. Product benchmarking
      • 7.5.1.4. Strategic initiatives
    • 7.5.2. OMRON Corporation
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial performance
      • 7.5.2.3. Product benchmarking
      • 7.5.2.4. Strategic initiatives
    • 7.5.3. Cook Medical PARI GmbH
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial performance
      • 7.5.3.3. Product benchmarking
      • 7.5.3.4. Strategic initiatives
    • 7.5.4. General Electric
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial performance
      • 7.5.4.3. Product benchmarking
      • 7.5.4.4. Strategic initiatives
    • 7.5.5. Allied Healthcare Products, Inc.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial performance
      • 7.5.5.3. Product benchmarking
      • 7.5.5.4. Strategic initiatives
    • 7.5.6. BD (Becton, Dickinson & Company)
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial performance
      • 7.5.6.3. Product benchmarking
      • 7.5.6.4. Strategic initiatives
    • 7.5.7. GF Health Products, Inc.
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial performance
      • 7.5.7.3. Product benchmarking
      • 7.5.7.4. Strategic initiatives
    • 7.5.8. Medline Industries, LP
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial performance
      • 7.5.8.3. Product benchmarking
      • 7.5.8.4. Strategic initiatives
    • 7.5.9. Briggs Healthcare
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial performance
      • 7.5.9.3. Product benchmarking
      • 7.5.9.4. Strategic initiatives
    • 7.5.10. Vectura Group Ltd
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial performance
      • 7.5.10.3. Product benchmarking
      • 7.5.10.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 4 North America pneumatic nebulizers market, by country, 2018 - 2030 (USD Million)
  • Table 5 North America pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 6 North America pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 7 U.S. pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 8 U.S. pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 10 Canada pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Mexico pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 12 Mexico pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Europe pneumatic nebulizers market, by country, 2018 - 2030 (USD Million)
  • Table 14 Europe pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 15 Europe pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 16 UK pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 17 UK pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Germany pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 19 Germany pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 20 France pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 21 France pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Italy pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 23 Italy pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Spain pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 25 Spain pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Norway pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 27 Norway pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Denmark pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 29 Denmark pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Sweden pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 31 Sweden pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific pneumatic nebulizers market, by country, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Japan pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 36 Japan pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 37 China pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 38 China pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 39 India pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 40 India pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Australia pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 42 Australia pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 43 South Korea pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 44 Thailand pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Thailand pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 46 Latin America pneumatic nebulizers market, by country, 2018 - 2030 (USD Million)
  • Table 47 Latin America pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 48 Latin America pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Brazil pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 50 Brazil pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Argentina pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 52 Argentina pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Middle East & Africa pneumatic nebulizers market, by country, 2018 - 2030 (USD Million)
  • Table 54 Middle East & Africa pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 55 MEA pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 56 South Africa pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 57 South Africa pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 60 UAE pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 61 UAE pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Kuwait pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 63 Kuwait pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market segmentation
  • Fig. 8 Market snapshot
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Market trends & outlook
  • Fig. 12 PESTLE analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Pneumatic nebulizers market: Indication outlook and key takeaways
  • Fig. 15 Pneumatic nebulizers market: Indication movement analysis
  • Fig. 16 Breath-actuated market, 2018 - 2030 (USD Million)
  • Fig. 17 Vented market, 2018 - 2030 (USD Million)
  • Fig. 18 Pneumatic nebulizers market: End use outlook and key takeaways
  • Fig. 19 Pneumatic nebulizers market: End use movement analysis
  • Fig. 20 Hospitals & clinics market, 2018 - 2030 (USD Million)
  • Fig. 21 Home healthcare market, 2018 - 2030 (USD Million)
  • Fig. 22 Regional marketplace: Key takeaways
  • Fig. 23 Regional outlook, 2024 & 2030
  • Fig. 24 Pneumatic nebulizers market: Region movement analysis
  • Fig. 25 North America pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 27 Canada pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 28 Mexico pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 29 Europe pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 30 UK pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 31 Germany pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 32 France pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 33 Italy pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 34 Spain pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 35 Spain pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 36 Norway pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 37 Denmark pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 38 Sweden pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 39 Asia Pacific pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 40 Japan pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 41 China pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 42 India pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 43 Australia pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 44 South Korea pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 45 Thailand pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 46 Latin America pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 47 Brazil pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 49 Middle East and Africa pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 52 UAE pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 53 Kuwait pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 54 Company categorization
  • Fig. 55 Strategy mapping
  • Fig. 56 Company market position analysis